Header Logo

Connection

RIVKAH COLEN to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications RIVKAH COLEN has written about Antibodies, Monoclonal.
RIVKAH COLEN
Connection Strength
0.063
Antibodies, Monoclonal
  1. Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience. Invest New Drugs. 2018 08; 36(4):638-646.
    View in: PubMed
    Score: 0.063
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.